Evidence map›Paper›PMID 25870296›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Enhancement of radiation effect on cancer cells by gold-pHLIP.

Michael P Antosh, Dayanjali D Wijesinghe, Samana Shrestha, Robert Lanou, Yun Hu Huang, Thomas Hasselbacher, David Fox, Nicola Neretti, Shouheng Sun, Natallia Katenka and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Atomically-precise AuJournal of nanobiotechnology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. BiVOJournal of nanobiotechnology · 2021
    Article
  14. Review
  15. Review
  16. An Experimental Study on [Molecular imaging · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.International journal of nanomedicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Michael P AntoshInstitute for Brain and Neural Systems and Department of Physics, Brown University, Providence, RI 02912;
Dayanjali D WijesinghePhysics Department, University of Rhode Island, Kingston, RI 02881;
Samana ShresthaPhysics Department, University of Rhode Island, Kingston, RI 02881;
Robert LanouDepartment of Physics, Brown University, Providence, RI 02912;
Yun Hu HuangDepartment of Physics, Brown University, Providence, RI 02912;
Thomas HasselbacherInstitute for Brain and Neural Systems and.
David FoxInstitute for Brain and Neural Systems and.
Nicola NerettiInstitute for Brain and Neural Systems and Department of Molecular Biology, Cell Biology and Biochemistry and.
Shouheng SunDepartment of Chemistry, Brown University, Providence, RI 02912; and.
Natallia KatenkaDepartment of Computer Science and Statistics, University of Rhode Island, Kingston, RI 02881.
Leon N CooperInstitute for Brain and Neural Systems and Department of Physics, Brown University, Providence, RI 02912; reshetnyak@mail.uri.edu Leon_Cooper@brown.edu.
Oleg A AndreevPhysics Department, University of Rhode Island, Kingston, RI 02881;
Yana K ReshetnyakPhysics Department, University of Rhode Island, Kingston, RI 02881; reshetnyak@mail.uri.edu Leon_Cooper@brown.edu.
Brown University · USUniversity of Rhode Island · US

Funding

Training CoreP20GM103430 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI Bongsup P Cho · 2012 to 2026
$63.6M
TM INTERACTIONS IN MEMBRANE PROTEIN FOLDING AND FUNCTIONR01GM073857 · NIGMS · YALE UNIVERSITY · PI ANDREEV, OLEG A, ENGELMAN, DONALD M. · 2006 to 2023
$8.4M
pHLIP Nanotechnology Platform for Cancer Imaging and TherapyR01CA133890 · NCI · UNIVERSITY OF RHODE ISLAND · PI ANDREEV, OLEG A, ENGELMAN, DONALD M. · 2008 to 2012
$3.8M
NCI NIH HHS CA133890NCI NIH HHS R01 CA133890NIGMS NIH HHS 2 P20 GM103430NIGMS NIH HHS GM073857NIGMS NIH HHS P20 GM103430NIGMS NIH HHS R01 GM073857
6 · The paper itself

Abstract

Previous research has shown that gold nanoparticles can increase the effectiveness of radiation on cancer cells. Improved radiation effectiveness would allow lower radiation doses given to patients, reducing adverse effects; alternatively, it would provide more cancer killing at current radiation doses. Damage from radiation and gold nanoparticles depends in part on the Auger effect, which is very localized; thus, it is important to place the gold nanoparticles on or in the cancer cells. In this work, we use the pH-sensitive, tumor-targeting agent, pH Low-Insertion Peptide (pHLIP), to tether 1.4-nm gold nanoparticles to cancer cells. We find that the conjugation of pHLIP to gold nanoparticles increases gold uptake in cells compared with gold nanoparticles without pHLIP, with the nanoparticles distributed mostly on the cellular membranes. We further find that gold nanoparticles conjugated to pHLIP produce a statistically significant decrease in cell survival with radiation compared with cells without gold nanoparticles and cells with gold alone. In the context of our previous findings demonstrating efficient pHLIP-mediated delivery of gold nanoparticles to tumors, the obtained results serve as a foundation for further preclinical evaluation of dose enhancement.

Indexed as

Gamma RaysGoldMembrane ProteinsNeoplasmsCell Line, TumorCell SurvivalHumansMetal NanoparticlesGoldMembrane ProteinspHLIP proteinaciditygold nanoparticlesradiationtargetingtumor

Identifiers

PMID25870296
PMCPMC4418858
OpenAlexW2143686498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.